SCHEMBL18024066

SCHEMBL18024066

Cc1cnc(F)c(NS(=O)(=O)CC(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.45
BRAF P15056 3/20 0.38
SLC40A1 Q9NP59 3/20 0.34
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34
ADRA2A P08913 1/20 0.33
LRRK2 Q5S007 1/20 0.33
CYP2C9 P11712 1/20 0.33
KMO O15229 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
FFAR1 O14842 1/20 0.32
PGR P06401 1/20 0.32
PPARG P37231 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18024067 0.87 CYP17A1 (0.46) CYP17A1BRAFSLC40A1CTSSCTSK
SCHEMBL18595670 0.84 PSIP1 (0.45) CYP2C9KDM4EALDH1A1GAAMAPT
SCHEMBL18595668 0.84 CYP17A1 (0.39) CYP17A1BRAFCTSSCTSKADRA2A
SCHEMBL19257395 0.81 CYP17A1 (0.37) CYP17A1BRAFCTSSCTSKADRA2A
SCHEMBL18595671 0.74 CYP17A1 (0.41) CYP17A1BRAFCTSSCTSKADRA2A
SCHEMBL19257097 0.72 CYP17A1 (0.39) CYP17A1BRAFCTSSCTSKADRA2A
SCHEMBL17996189 0.70 PSIP1 (0.42) ALDH1A1HPGDPSIP1
SCHEMBL18595669 0.68 BRD4 (0.44) CYP2C9KDM4EALDH1A1GAAMAPT
SCHEMBL27688260 0.68 NOS3 (0.35) ADRA2AFFAR1
SCHEMBL19748091 0.68 PSIP1 (0.44) BRAFMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016130501-A1 AZA-HETEROARYL COMPOUNDS AS PI3K-GAMMA INHIBITORS INCYTE CORPORATION (US) 2016-08-18 WO disclosed